温阳化气论治非酒精性脂肪性肝病

doi:10.3736/jcim20110203

Abstract

Fatty liver disease is caused by abnormal accumulation of lipids within hepatocytes. According to traditional Chinese medicine (TCM) theory, lipids belong to the category of essence obtained from cereals and the normal distribution of essence relies on the function of spleen yang. When spleen yang is injured, the normal distribution of essence (lipids) will be affected, leading to formation of phlegm retention in the liver. That is the TCM pathogenesis of fatty liver disease. Hence the treatment of fatty liver disease should be concentrated on warming yang to activate qi. With such a treatment, the normal distribution of essence will be restored, essence will be distributed, and phlegm will be dissipated.

Key words: fatty liver disease, spleen governing the dissipation of essence, deficiency of spleen-yang, warming yang to activate qi

Tao Liu, Zhi-peng Tang, Guang Ji. Treatment of non-alcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi. Journal of Chinese Integrative Medicine, 2011, 9(2): 135-137.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20110203

http://www.jcimjournal.com/EN/Y2011/V9/I2/135

TrendMD

References 8

[1]	Yao GB. Clinical hepatology[M]. Shanghai: Shanghai scientific and Technical Publishers, 2004: 550, 553
	姚光弼 . 临床肝脏病学[M]. 上海: 上海科学技术出版社, 2004: 550, 553
[2]	Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases[J]. Zhonghua Gan Zang Bing Za Zhi, 2006,14(3):161-163
	中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南[J]. 中华肝脏病杂志, 2006,14(3):161-163
[3]	Friedman LS, Keefe EB. Translated by Niu JQ, Zhang QQ, Ding YH.Handbook of liver disease(2nd ed)[M]. Tianjin: Tianjin Science and Technology Translation and Publishing Corp, 2007: 97, 102
	Friedman LS, Keefe EB. 牛俊奇, 张清泉, 丁艳华, 译.肝病手册(第2版)[M]. 天津: 天津科技翻译出版公司, 2007: 97, 102
[4]	Fan JG, Zeng MD. Fatty liver disease[M]. Beijing: People’s Medical Publishing House, 2005: 118
	范建高, 曾民德 . 脂肪性肝病[M]. 北京: 人民卫生出版社, 2005: 118
[5]	Zhu DN. Physiology(7th ed)[M]. Beijing: People’s Medical Publishing House, 2009: 192
	朱大年.生理学( 第7版)[M]. 北京: 人民卫生出版社, 2009: 192
[6]	Zhou MS. Biochemistry[M]. Shanghai: Shanghai Scientific and Technical Publishers, 1995: 157
	周梦圣 . 生物化学[M]. 上海: 上海科学技术出版社, 1995: 157
[7]	Wang HT. Neijing teaching materials[M]. Beijing: People’s Medical Publishing House, 2002: 64, 72
	王洪图 . 内经讲义[M]. 北京: 人民卫生出版社, 2002: 64, 72
[8]	Wei HF, Liu T, Xing LJ, Zheng PY, Ji G . Distribution pattern of traditional Chinese medicine syndromes in 793 patients with fatty liver disease[J]. J Chin Integr Med, 2009,7(5):411-417
	魏华凤, 柳涛, 邢练军, 郑培永, 季光 . 793例脂肪肝患者证候分布规律[J]. 中西医结合学报, 2009,7(5):411-417

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2]	Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3]	Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4]	SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5]	Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6]	Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7]	Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8]	Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9]	Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10]	Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239

Treatment of non-alcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi

RichHTML

PDF (PC)

Like

Abstract

Cite this article

Share this article

TrendMD

References 8

Related Articles 4

Metrics

Comments

Recommended 10

[1]	Meng-ya Shan, Ying Dai, Xiao-dan Ren, Jing Zheng, Ke-bin Zhang, Bin Chen, Jun Yan, Zi-hui Xu. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. Journal of Integrative Medicine, 2021, 19(6): 545-554.
[2]	Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[3]	Hui Zhang, Qin Feng, Hong-shan Li, Shao-dong Chen, Xiao-ning Wang, Jing-hua Peng, Ning Zhang, Yi-yang Hu. Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-α expression in rats with non-alcoholic steatohepatitis. Journal of Chinese Integrative Medicine, 2008, 6(9): 928-933.
[4]	Xiao-yi Zhang, Cheng-bao Kuang. Clinical observation on treatment of nonalcoholic fatty liver disease complicating hyperuricemia by Zhifang Ⅰ Decoction. Journal of Chinese Integrative Medicine, 2004, 2(4): 265-267.